Evidence map›Paper›PMID 35561428›Full record

ArticleJournal of neuroimmunology2022

COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia with excellent response to methylprednisolone: A case report.

Md Asaduzzaman, Bidrum Purkayastha, M M Jahangir Alam, Shishir Ranjan Chakraborty, Soumitra Roy, Nasad Ahmed

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of neuroimmunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Neurological Adverse Reactions to SARS-CoV-2 Vaccines.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2023
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Md AsaduzzamanDepartment of Medicine, Sylhet MAG Osmani Medical College Hospital, Sylhet 3100, Bangladesh. Electronic address: asad_somc@yahoo.com.
Bidrum PurkayasthaDepartment of Medicine, Sylhet MAG Osmani Medical College Hospital, Sylhet 3100, Bangladesh. Electronic address: miaohalum@gmail.com.
M M Jahangir AlamDepartment of Medicine, Sylhet MAG Osmani Medical College Hospital, Sylhet 3100, Bangladesh. Electronic address: mmjalam@gmail.com.
Shishir Ranjan ChakrabortyDepartment of Medicine, Sylhet MAG Osmani Medical College Hospital, Sylhet 3100, Bangladesh. Electronic address: chakrabortysrdr@gmail.com.
Soumitra RoyDepartment of Medicine, Sylhet MAG Osmani Medical College Hospital, Sylhet 3100, Bangladesh. Electronic address: dr.soumitra68@gmail.com.
Nasad AhmedDepartment of Medicine, Sylhet MAG Osmani Medical College Hospital, Sylhet 3100, Bangladesh. Electronic address: nasadahmed@gmail.com.
Sylhet MAG Osmani Medical College · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLarge-scale vaccination is considered one of the most effective strategies to control the pandemic of COVID-19. Since its start, different complications have been described thought to be related to vaccination. Here, we present a rare case where encephalopathy, myocarditis, and thrombocytopenia developed simultaneously following the second dose of Pfizer-BioNTech mRNA vaccine (BNT162b2). CASE PRESENTATION: A 15-years-old female presented with fever, altered consciousness, and convulsions after taking the second shot of the vaccine. Clinical and laboratory workup was notable for the presence of thrombocytopenia and myocarditis. No alternative causes of encephalitis were found. The patient responded significantly to methylprednisolone suggesting underlying immune pathogenesis responsible for the clinical features. The diagnostic criteria for possible autoimmune encephalitis were also fulfilled.

conclusionAlthough rare, the clinician should be aware of the possible adverse events following COVID-19 vaccination. Further research with large pooled data is needed to get more insight into its pathogenesis and causal relationship.

Indexed as

Brain DiseasesCOVID-19EncephalitisMyocarditisThrombocytopeniaAdolescentBNT162 VaccineCOVID-19 VaccinesFemaleHumansMethylprednisolonemRNA VaccinesVaccines, SyntheticBNT162 VaccineCOVID-19 VaccinesMethylprednisolonemRNA VaccinesVaccines, SyntheticCase reportMyocarditisPfizer-BioNTech mRNA vaccine (BNT162b2)SARS-CoV-2ThrombocytopeniaVaccine-associated encephalopathy

Identifiers

PMID35561428
PMCPMC9080027
OpenAlexW4229334005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.